Cohesin and CTCF differentially regulate spatiotemporal runx1 expression during zebrafish development

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 1, 2014, Pages 50-61

  Marsman, Judith ^a   O'Neill, Adam C ^a   Kao, Betty Rui Yun ^a   Rhodes, Jenny M ^a   Meier, Michael ^a   Antony, Jisha ^a   Mönnich, Maren ^a   Horsfield, Julia A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cohesin; CTCF; Hematopoiesis; Rad21; Runx1; Zebrafish

Indexed keywords

COHESIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR RUNX1;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENETIC CONSERVATION; HISTONE MODIFICATION; IN SITU HYBRIDIZATION; IN VIVO STUDY; INTRON; MESODERM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIOTEMPORAL ANALYSIS; TAIL; WESTERN BLOTTING; ZEBRA FISH;

ALM; ANTERIOR LATERAL MESODERM; CCCTC-BINDING FACTOR; CIS-REGULATORY ELEMENT; COHESIN; CRE; CTCF; HEMATOPOIESIS; ICM; INTERMEDIATE CELL MASS; MO; MORPHOLINO OLIGONUCLEOTIDE; PLM; POSTERIOR LATERAL MESODERM; RAD21; RB; RNA POLYMERASE II; RNAPII; ROHON-BEARD NEURONS; RUNX1; TRANSCRIPTION START SITE; TSS; ZEBRAFISH;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESODERM; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84891480203     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.11.007     Document Type: Article

References (60)

1. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3444-3449.
2. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
3. Growney J.D., Shigematsu H., Li Z., Lee B.H., Adelsperger J., Rowan R., Curley D.P., Kutok J.L., Akashi K., Williams I.R., Speck N.A., Gilliland D.G. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005, 106:494-504.
4. Ichikawa M., Asai T., Saito T., Seo S., Yamazaki I., Yamagata T., Mitani K., Chiba S., Ogawa S., Kurokawa M., Hirai H. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 2004, 10:299-304.
5. Chen M.J., Yokomizo T., Zeigler B.M., Dzierzak E., Speck N.A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457:887-891.
6. Swiers G., de Bruijn M., Speck N.A. Hematopoietic stem cell emergence in the conceptus and the role of Runx1. Int. J. Dev. Biol. 2010, 54:1151-1163.
7. Bee T., Swiers G., Muroi S., Pozner A., Nottingham W., Santos A.C., Li P.S., Taniuchi I., de Bruijn M.F. Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis. Blood 2010, 115:3042-3050.
8. Inoue K., Shiga T., Ito Y. Runx transcription factors in neuronal development. Neural Dev. 2008, 3:20.
9. Kramer I., Sigrist M., de Nooij J.C., Taniuchi I., Jessell T.M., Arber S. A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification. Neuron 2006, 49:379-393.
10. Theriault F.M., Roy P., Stifani S. AML1/Runx1 is important for the development of hindbrain cholinergic branchiovisceral motor neurons and selected cranial sensory neurons. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10343-10348.
11. de Bruijn M.F., Speck N.A. Core-binding factors in hematopoiesis and immune function. Oncogene 2004, 23:4238-4248.
12. Levanon D., Groner Y. Structure and regulated expression of mammalian RUNX genes. Oncogene 2004, 23:4211-4219.
13. Rennert J., Coffman J.A., Mushegian A.R., Robertson A.J. The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms. BMC Evol. Biol. 2003, 3:4.
14. Ghozi M.C., Bernstein Y., Negreanu V., Levanon D., Groner Y. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1935-1940.
15. Fujita Y., Nishimura M., Taniwaki M., Abe T., Okuda T. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development. Biochem. Biophys. Res. Commun. 2001, 281:1248-1255.
16. Pozner A., Goldenberg D., Negreanu V., Le S.Y., Elroy-Stein O., Levanon D., Groner Y. Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms. Mol. Cell. Biol. 2000, 20:2297-2307.
17. Bae S.C., Ogawa E., Maruyama M., Oka H., Satake M., Shigesada K., Jenkins N.A., Gilbert D.J., Copeland N.G., Ito Y. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 1994, 14:3242-3252.
18. Bee T., Liddiard K., Swiers G., Bickley S.R., Vink C.S., Jarratt A., Hughes J.R., Medvinsky A., de Bruijn M.F. Alternative Runx1 promoter usage in mouse developmental hematopoiesis. Blood Cells Mol. Dis. 2009, 43:35-42.
19. Pozner A., Lotem J., Xiao C., Goldenberg D., Brenner O., Negreanu V., Levanon D., Groner Y. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev. Biol 2007, 7:84.
20. Challen G.A., Goodell M.A. Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells. Exp. Hematol. 2010, 38:403-416.
21. Mikhail F.M., Sinha K.K., Saunthararajah Y., Nucifora G. Normal and transforming functions of RUNX1: a perspective. J. Cell. Physiol. 2006, 207:582-593.
22. Yamagata T., Maki K., Mitani K. Runx1/AML1 in normal and abnormal hematopoiesis. Int. J. Hematol. 2005, 82:1-8.
23. Kalev-Zylinska M.L., Horsfield J.A., Flores M.V., Postlethwait J.H., Vitas M.R., Baas A.M., Crosier P.S., Crosier K.E. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 2002, 129:2015-2030.
24. Horsfield J., Anagnostou S., Hu J.K.H., Cho K.H.-Y., Geisler R., Lieschke G., Crosier K., Crosier P. Cohesin-dependent regulation of runx genes. Development 2007, 134:2639-2649.
25. Markova E.N., Kantidze O.L., Razin S.V. Transcriptional regulation and spatial organisation of the human AML1/RUNX1 gene. J. Cell. Biochem. 2011, 112:1997-2005.
26. Bee T., Ashley E.L., Bickley S.R., Jarratt A., Li P.S., Sloane-Stanley J., Gottgens B., de Bruijn M.F. The mouse Runx1 +23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters. Blood 2009, 113:5121-5124.
27. Ng C.E., Yokomizo T., Yamashita N., Cirovic B., Jin H., Wen Z., Ito Y., Osato M. A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells. Stem Cells 2010, 28:1869-1881.
28. Nottingham W.T., Jarratt A., Burgess M., Speck C.L., Cheng J.F., Prabhakar S., Rubin E.M., Li P.S., Sloane-Stanley J., Kong A.S.J., de Bruijn M.F. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood 2007, 110:4188-4197.
29. Lam E.Y., Chau J.Y., Kalev-Zylinska M.L., Fountaine T.M., Mead R.S., Hall C.J., Crosier P.S., Crosier K.E., Flores M.V. Zebrafish runx1 promoter-EGFP transgenics mark discrete sites of definitive blood progenitors. Blood 2009, 113:1241-1249.
30. Nasmyth K., Haering C.H. Cohesin: its roles and mechanisms. Annual Review of Genetics 2009.
31. Dorsett D., Merkenschlager M. Cohesin at active genes: a unifying theme for cohesin and gene expression from model organisms to humans. Curr. Opin. Cell Biol. 2013, 25(3):327-333.
32. Dorsett D., Strom L. The ancient and evolving roles of cohesin in gene expression and DNA repair. Curr. Biol. 2012, 22:R240-R250.
33. Merkenschlager M., Odom D.T. CTCF and cohesin: linking gene regulatory elements with their targets. Cell 2013, 152:1285-1297.
34. Herold M., Bartkuhn M., Renkawitz R. CTCF: insights into insulator function during development. Development 2012, 139:1045-1057.
35. Handoko L., Xu H., Li G., Ngan C.Y., Chew E., Schnapp M., Lee C.W., Ye C., Ping J.L., Mulawadi F., Wong E., Sheng J., Zhang Y., Poh T., Chan C.S., Kunarso G., Shahab A., Bourque G., Cacheux-Rataboul V., Sung W.K., Ruan Y., Wei C.L. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat. Genet. 2011, 43:630-638.
36. Parelho V., Hadjur S., Spivakov M., Leleu M., Sauer S., Gregson H.C., Jarmuz A., Canzonetta C., Webster Z., Nesterova T., Cobb B.S., Yokomori K., Dillon N., Aragon L., Fisher A.G., Merkenschlager M. Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell 2008, 132:422-433.
37. Rubio E.D., Reiss D.J., Welcsh P.L., Disteche C.M., Filippova G.N., Baliga N.S., Aebersold R., Ranish J.A., Krumm A. CTCF physically links cohesin to chromatin. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:8309-8314.
38. Stedman W., Kang H., Lin S., Kissil J.L., Bartolomei M.S., Lieberman P.M. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J. 2008, 27:654-666.
39. Marsman J., Horsfield J.A. Long distance relationships: enhancer-promoter communication and dynamic gene transcription. Biochim. Biophys. Acta 2012, 1819:1217-1227.
40. Hirayama T., Tarusawa E., Yoshimura Y., Galjart N., Yagi T. CTCF is required for neural development and stochastic expression of clustered pcdh genes in neurons. Cell Rep. 2012, 2(2):345-357.
41. Guo Y., Monahan K., Wu H., Gertz J., Varley K.E., Li W., Myers R.M., Maniatis T., Wu Q. CTCF/cohesin-mediated DNA looping is required for protocadherin alpha promoter choice. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:21081-21086.
42. Monahan K., Rudnick N., Kehayova P., Pauli F., Newberry K., Myers R., Maniatis T. Role of CCCTC binding factor (CTCF) and cohesin in the generation of single-cell diversity of Protocadherin-αgene expression. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9125-9155.
43. Westerfield M. The zebrafish book. A Guide for the Laboratory Use of Zebrafish (Danio rerio) 1995, University of Oregon Press, Eugene, OR. 3rd edition.
44. Rhodes J.M., Bentley F.K., Print C.G., Dorsett D., Misulovin Z., Dickinson E.J., Crosier K.E., Crosier P.S., Horsfield J.A. Positive regulation of c-Myc by cohesin is direct, and evolutionarily conserved. Dev. Biol. 2010, 344:637-649.
45. McEwan M.V., Eccles M.R., Horsfield J.A. Cohesin is required for activation of MYC by estradiol. PLoS ONE 2012, 7:e49160.
46. Pfaffl M. Quantification strategies in real-time PCR. A-Z of Quantitative PCR 2004, vol. 1:87-112. International University Line (IUL) La Jolla, CA, USA. S.A. Bustin (Ed.).
47. Bao L., Zhou M., Cui Y. CTCFBSDB: a CTCF-binding site database for characterization of vertebrate genomic insulators. Nucleic Acids Res. 2008, 36:D83-D87.
48. Bessa J., Tena J.J., de la Calle-Mustienes E., Fernandez-Minan A., Naranjo S., Fernandez A., Montoliu L., Akalin A., Lenhard B., Casares F., Gomez-Skarmeta J.L. Zebrafish enhancer detection (ZED) vector: a new tool to facilitate transgenesis and the functional analysis of cis-regulatory regions in zebrafish. Dev. Dyn. 2009, 238:2409-2417.
49. Kawakami K. Transposon tools and methods in zebrafish. Dev. Dyn. 2005, 234:244-254.
50. Eroglu B., Wang G., Tu N., Sun X., Mivechi N.F. Critical role of Brg1 member of the SWI/SNF chromatin remodeling complex during neurogenesis and neural crest induction in zebrafish. Dev. Dyn. 2006, 235:2722-2735.
51. Wendt K.S., Peters J.M. How cohesin and CTCF cooperate in regulating gene expression. Chromosom. Res. 2009, 17:201-214.
52. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., Boyer L.A., Young R.A., Jaenisch R. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21931-21936.
53. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., Wang W., Weng Z., Green R.D., Crawford G.E., Ren B. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
54. Rada-Iglesias A., Bajpai R., Swigut T., Brugmann S.A., Flynn R.A., Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
55. Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. Curr. Protoc. Bioinforma. 2008, Chapter 2, (Chapter 2:Unit 2.6).
56. Schmidt D., Schwalie P., Ross-Innes C.S., Hurtado A., Brown G., Carroll J., Flicek P., Odom D. A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res. 2010, 20(5):578-588.
57. Supernat A., Lapinska-Szumczyk S., Sawicki S., Wydra D., Biernat W., Zaczek A.J. Deregulation of RAD21 and RUNX1 expression in endometrial cancer. Oncol. Lett. 2012, 4:727-732.
58. N.Cancer Genome Atlas Research Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 2013, 368:2059-2074.
59. Welch J.S., Ley T.J., Link D.C., Miller C.A., Larson D.E., Koboldt D.C., Wartman L.D., Lamprecht T.L., Liu F., Xia J., Kandoth C., Fulton R.S., McLellan M.D., Dooling D.J., Wallis J.W., Chen K., Harris C.C., Schmidt H.K., Kalicki-Veizer J.M., Lu C., Zhang Q., Lin L., O'Laughlin M.D., McMichael J.F., Delehaunty K.D., Fulton L.A., Magrini V.J., McGrath S.D., Demeter R.T., Vickery T.L., Hundal J., Cook L.L., Swift G.W., Reed J.P., Alldredge P.A., Wylie T.N., Walker J.R., Watson M.A., Heath S.E., Shannon W.D., Varghese N., Nagarajan R., Payton J.E., Baty J.D., Kulkarni S., Klco J.M., Tomasson M.H., Westervelt P., Walter M.J., Graubert T.A., DiPersio J.F., Ding L., Mardis E.R., Wilson R.K. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012, 150:264-278.
60. Yoshida K., Toki T., Okuno Y., Kanezaki R., Shiraishi Y., Sato-Otsubo A., Sanada M., Park M.J., Terui K., Suzuki H., Kon A., Nagata Y., Sato Y., Wang R., Shiba N., Chiba K., Tanaka H., Hama A., Muramatsu H., Hasegawa D., Nakamura K., Kanegane H., Tsukamoto K., Adachi S., Kawakami K., Kato K., Nishimura R., Izraeli S., Hayashi Y., Miyano S., Kojima S., Ito E., Ogawa S. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat. Genet. 2013, 1293-1299.